{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:53:12Z","timestamp":1782816792114,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.canrad.2017.07.023","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T21:30:39Z","timestamp":1503091839000},"page":"521-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["R\u00e9irradiation des cancers des voies a\u00e9rodigestives sup\u00e9rieures"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4646-4778","authenticated-orcid":false,"given":"J.","family":"Doyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lam Cham Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guigay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dassonville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Peyrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Poissonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sa\u00e2da-Bouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sudaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bozec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"B\u00e9n\u00e9zery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2017.07.023_bib0180","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijrobp.2012.05.008","article-title":"Long-term follow-up of the RTOG 9501\/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck","volume":"84","author":"Cooper","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0185","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mdh308","article-title":"Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience","volume":"15","author":"Brockstein","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0190","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2017.07.023_bib0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.20697","article-title":"Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck","volume":"30","author":"Spencer","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2017.07.023_bib0200","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","article-title":"Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911","volume":"25","author":"Langer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hed.23542","article-title":"Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate","volume":"37","author":"Strojan","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2017.07.023_bib0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.oraloncology.2016.07.012","article-title":"Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences","volume":"61","author":"Margalit","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0215","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2016.03.015","article-title":"Reirradiation of head and neck cancers with intensity modulated radiation therapy: outcomes and analyses","volume":"95","author":"Takiar","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0220","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.ijrobp.2011.01.004","article-title":"Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity","volume":"81","author":"Hoebers","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0225","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1200\/JCO.2007.15.0102","article-title":"Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma","volume":"26","author":"Janot","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0230","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.1989.7.6.761","article-title":"Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I\u2013II study","volume":"7","author":"Vokes","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0235","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijrobp.2005.07.005","article-title":"Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma","volume":"64","author":"Salama","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0240","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1200\/JCO.1998.16.11.3556","article-title":"Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169\u00a0patients","volume":"16","author":"De Crevoisier","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2015.00256","article-title":"Increase in tumor control and normal tissue complication probabilities in advanced head-and-neck cancer for dose-escalated intensity-modulated photon and proton therapy","volume":"5","author":"Jakobi","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0250","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3109\/0284186X.2015.1071920","article-title":"NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy","volume":"54","author":"Jakobi","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0255","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ijrobp.2015.04.031","article-title":"Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis","volume":"92","author":"Jakobi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0260","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.otohns.2008.09.002","article-title":"Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma","volume":"139","author":"Suh","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2017.07.023_bib0265","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hed.24733","article-title":"Reirradiation of head and neck cancer: long-term disease control and toxicity","volume":"39","author":"Bots","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2017.07.023_bib0270","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijrobp.2016.02.036","article-title":"Proton beam reirradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes","volume":"95","author":"Romesser","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0275","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2013.08.012","article-title":"Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer","volume":"109","author":"Lartigau \u00c9F","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0280","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ijrobp.2009.06.070","article-title":"Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer","volume":"77","author":"Unger","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0285","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ijrobp.2008.12.075","article-title":"Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial","volume":"75","author":"Heron","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijrobp.2011.11.054","article-title":"Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study","volume":"84","author":"Comet","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-3284-1-13","article-title":"Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis","volume":"1","author":"Chua","year":"2009","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1748-717X-8-7","article-title":"Stereotactic body radiation therapy in the re-irradiation situation\u00a0\u2013\u00a0a review","volume":"8","author":"Mantel","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0305","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1586\/era.12.97","article-title":"Reirradiation for recurrent head and neck cancer","volume":"12","author":"Patel","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.canrad.2017.07.023_bib0310","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2006.02.003","article-title":"A phase II study of primary reirradiation in squamous cell carcinoma of head and neck","volume":"78","author":"Langendijk","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0315","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.04.021","article-title":"IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes","volume":"73","author":"Sulman","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.023_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3857\/roj.2017.00122","article-title":"Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.canrad.2017.07.023_bib0325","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00000421-200208000-00018","article-title":"Prognostic factors of reirradiation for recurrent head and neck cancer","volume":"25","author":"Ohizumi","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0330","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0335","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1200\/JCO.2016.70.1524","article-title":"Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study","volume":"35","author":"Bauml","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0340","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/annonc\/mdw417","article-title":"Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1\u00a0therapy, anti-CTLA-4\u00a0therapy, BRAF\/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy","volume":"27","author":"Ahmed","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0345","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/annonc\/mdv622","article-title":"Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1\u00a0therapy","volume":"27","author":"Ahmed","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2017.07.023_bib0175","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181730207X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181730207X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:30:05Z","timestamp":1761136205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832181730207X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S127832181730207X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2017.07.023","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9irradiation des cancers des voies a\u00e9rodigestives sup\u00e9rieures","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2017.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}